<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379583</url>
  </required_header>
  <id_info>
    <org_study_id>FI-HairDX-001</org_study_id>
    <nct_id>NCT04379583</nct_id>
  </id_info>
  <brief_title>HairDx Analytical Validation Study</brief_title>
  <official_title>HairDx Analytical Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applied Biology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applied Biology, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HairDx Test reports genetic variants associated with the development of FPHL.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The HairDx Test reports genetic variants associated with the development of FPHL. The
      variants are detected from a saliva sample collected at home. The HairDx Test report is
      designed to help individuals understand the meaning of their results and encourage a
      conversation with a healthcare professional. The information provided by the HairDx Test
      report is not intended to start, stop or change any course of treatment. The purpose of this
      study is to collect DNA samples from subjects. The DNA samples will be used for the
      analytical validation of the HairDx Test. The results of this study will not be shared with
      the subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">October 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 6, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of the accuracy of the HairDx Test</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of the accuracy of the HairDx Test in comparison to bi-directional Sanger sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determination of the precision and reproducibility of HairDx Test</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of the precision and reproducibility of HairDx Test in accordance with the laboratory instructions for use documentation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hair Loss</condition>
  <condition>Hair Loss/Baldness</condition>
  <condition>Female Pattern Baldness</condition>
  <condition>Androgenetic Alopecia</condition>
  <arm_group>
    <arm_group_label>Subjects</arm_group_label>
    <description>Female subjects providing DNA saliva sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HairDx Sample Collection Kit</intervention_name>
    <description>Saliva collection using FDA OTC cleared sample collection device</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva DNA sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects recruited from an online advertisement approved by the IRB
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females over the age of 18

          -  Overall good health

          -  Able to give informed consent

          -  Willing to collect saliva sample

        Exclusion Criteria:

          -  Xerostomia (dry mouth)

          -  Inability to provide informed consent in English

          -  Inability to follow instructions for saliva sample collection

          -  Non US resident
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female over the age of 18</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>John McCoy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Applied Biology, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Naegle</last_name>
    <phone>9493874526</phone>
    <email>monican@appliedbiology.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Applied Biology, Inc.</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Naegle</last_name>
      <phone>949-387-4526</phone>
      <email>monican@appliedbiology.com</email>
    </contact>
    <investigator>
      <last_name>John McCoy, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Redler S, Birch P, Drichel D, Hofmann P, Dobson K, Böhmer AC, Becker J, Giehl KA, Tazi-Ahnini R, Kruse R, Wolff H, Miesel A, Fischer T, Böhm M, Nuwayhid R, Garcia Bartels N, Lutz G, Becker T, Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC. The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patients. Br J Dermatol. 2014 Apr;170(4):982-5. doi: 10.1111/bjd.12756.</citation>
    <PMID>24344880</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will only be shared with FDA.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

